A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
10/2002
10/30/2002	EP1252158A1 Nicotinamide benzofused-heterocyclyl derivatives useful as selective inhibitors of pde4 isozymes
10/30/2002	EP1252157A1 Pyrimidine carboxamides useful as inhibitors of pde4 isozymes
10/30/2002	EP1252154A1 Heterocyclic amide derivatives
10/30/2002	EP1252145A1 Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesis
10/30/2002	EP1252144A1 Substituted glutarimides and use thereof il-12 production inhibitors
10/30/2002	EP1252143A1 Method for preparing alpha-sulfonyl hydroxamic acid derivatives
10/30/2002	EP1252141A1 Tosylproline analogs as thymidylate synthase inhibitors
10/30/2002	EP1252133A2 Pharmaceutical compounds
10/30/2002	EP1251874A1 Stabilised pharmaceutical compositions and process for their preparation comprising an antibiotic and an expectorant
10/30/2002	EP1251871A1 Pharmaceutical composition for immunomodulation and preparation of vaccines comprising an antigen and an immunogenic oligodeoxynucleotide and a polycationic polymer as adjuvants
10/30/2002	EP1251869A2 Compositions and method for preventing reactogenicity associated with administration of immunogenic live rotavirus compositions
10/30/2002	EP1251864A1 Pharmaceutical formulation composed of a polymer blend and an active compound for time-controlled release
10/30/2002	EP1251849A1 Gyrase inhibitors and uses thereof
10/30/2002	EP1251848A1 Gyrase inhibitors and uses thereof
10/30/2002	EP1251840A2 Method for using potassium channel activation for delivering a medicant to an abnormal brain region and/or a malignant tumor
10/30/2002	EP1251829A1 Electrospun pharmaceutical compositions
10/30/2002	EP1251827A2 Nasally administrable cyclic peptide compositions
10/30/2002	EP1251747A2 Pet food composition for treating helicobacter species in pets
10/30/2002	EP1204667A4 An improved amorphous form of cefpodoxime proxetil
10/30/2002	EP1155018B1 Crystal modification c of 8-cyano-1-cyclopropyl-7- (1s, 6s-2,8- diazabicyclo - 4.3.0] nonan-8-yl) -6-fluoro-1,4-dihydro-4-oxo-3-quinoline carboxylic
10/30/2002	EP1091774B1 Bone cement with antimicrobial peptides
10/30/2002	EP0915707B1 Pharmaceutical composition comprising serum amyloid p component for prophylactic or therapeutic treatment of virus infections and a kit for detecting binding of compositions to virus components
10/30/2002	EP0726911B1 Treatment of hematologic disorders with a igf-1/igfbp-3 complex
10/30/2002	EP0699076B1 Otitis media vaccine
10/30/2002	EP0689449B1 Therapeutical compositions for use in humans, characterised by a combination of a muramyl peptide and a cytokine
10/30/2002	CN1377424A Methods of reparing tandemly repeated DNA sequences and extending cell life-span using nuclear transfer
10/30/2002	CN1377415A 疫苗组合物 Vaccine composition
10/30/2002	CN1377411A BASB 119 polypeptide and polynucleotide from noraxella catarrhalis
10/30/2002	CN1377410A Nucleic acids and proteins from group B streptoccus
10/30/2002	CN1377408A The PRV-1 gene and use thereof
10/30/2002	CN1377405A Personal care articles
10/30/2002	CN1377352A Selective antagonists of A28 adenosine receptors
10/30/2002	CN1377346A Z-pyrazoline-5-ones
10/30/2002	CN1377344A Inhibitor of cysteinyl aspartic acid proteinase
10/30/2002	CN1377341A Amycomycin, production thereof and its use as pharmaceutical
10/30/2002	CN1377275A Peptides that block viral infectivity and methods of use thereof
10/30/2002	CN1377274A Treatment of chronic viral infections with i (M. Vannae)
10/30/2002	CN1377268A Cell adhesion inhibitors
10/30/2002	CN1377267A Retard form containing 2-lipoic acid (derivatives)
10/30/2002	CN1377262A Method and composition for prophylaxis and treatment of symptoms associated with cold and influenza-like illnesses
10/30/2002	CN1377261A Treatment of immune diseases
10/30/2002	CN1377235A Nutritional compositions which contain non-digestible polysaccharides and use thereof to reduce transport through tight junctions
10/30/2002	CN1376735A Antibiotics-polymer composition
10/30/2002	CN1376509A Chinese medicine for treating tuberculosis
10/30/2002	CN1376507A Medicine for treating beriberi and its preparing process
10/30/2002	CN1376501A Compound sarcandra glabra injection
10/30/2002	CN1376485A Spray for preventing and treating cold
10/30/2002	CN1376478A Medicine for treating AIDS and its preparing process
10/30/2002	CN1376459A Preparation method for antibiotics composition
10/30/2002	CN1093535C Imiazole derivative
10/30/2002	CN1093408C Composition of radio sophorae flavescentis green tea and preparation thereof and its application in treating condyloma
10/30/2002	CA2383469A1 Treatment of t-cell mediated diseases
10/29/2002	US6472534 Treating tetrahydrofuran derivativ with an oxophilic electrophilic reagent in a manner that is effective to provide the oxazoline compound
10/29/2002	US6472529 Viricides
10/29/2002	US6472434 Vasoactive agent is administered to the vagina, vulvar area or urethra of the individual undergoing treatment. suitable vasoactive agents are vasodilators, including naturally occurring prostaglandins, synthetic prostaglandin derivatives,
10/29/2002	US6472412 Compounds as PDE IV and TNF inhibitors
10/29/2002	US6472407 α and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
10/29/2002	US6472406 Sulfonamidomethyl phosphonate inhibitors of beta-lactamase
10/29/2002	US6472404 HIV protease inhibitors
10/29/2002	US6472403 αV integrin receptor antagonists
10/29/2002	US6472396 Barbituric acid derivatives, processes for their production and pharmaceutical agents containing these compounds
10/29/2002	US6472384 Antimicrobial compounds
10/29/2002	US6472372 6-O-Carbamoyl ketolide antibacterials
10/29/2002	US6472371 Macrolides
10/29/2002	US6472180 A polynucleotide which encodes a truncated fragment of the hcv ns3 (hepatitis c virus)ns3 protein helicase fragment, such truncated fragment retaining helicase activity and having about 50 amino acids of carboxy terminus deleted
10/29/2002	US6472172 DNA encoding a novel human inhibitor-of-apoptosis protein
10/29/2002	US6472159 Use of an amphipathic compound for providing an adjuvant to a subunit vaccine
10/29/2002	US6471970 Use of pharmaceutical compositions capable of being gelled in periodontology
10/29/2002	US6471968 Multifunctional nanodevice platform
10/29/2002	US6471967 Recombinant intracellular pathogen vaccines and methods for use
10/29/2002	US6471964 Designated as structural protein-1 (sp-1), the isolated sp-1 protein, and use of the nucleic acid and/or protein for diagnostic or vaccine purposes
10/29/2002	CA2221242C Viral agent associated with mystery swine disease
10/29/2002	CA2210492C Neuraminic acid derivatives, their preparation and their medical use
10/29/2002	CA2179988C Pharmaceutical formulations comprising polythiourea and method of use thereof
10/29/2002	CA2115053C Antimicrobial dialdehyde composition and methods of use
10/25/2002	WO2001078652A2 Methods for drug discovery, disease treatment, and diagnosis using metabolomics
10/25/2002	CA2443806A1 Methods for drug discovery, disease treatment, and diagnosis using metabolomics
10/24/2002	WO2002084294A2 Gastrointestinal glutathione peroxidase in hepatitis c virus infections
10/24/2002	WO2002083926A2 Methods of diagnosing and treating small intestinal bacterial overgrowth (sibo) and sibo-related conditions
10/24/2002	WO2002083898A1 Full-length human cdnas encoding potentially secreted proteins
10/24/2002	WO2002083890A2 Use of clya hemolysin for excretion of fusion proteins
10/24/2002	WO2002083879A2 Immunotherapy based on dendritic cells
10/24/2002	WO2002083873A2 Enzymes
10/24/2002	WO2002083870A2 Pufa polyketide synthase systems and uses thereof
10/24/2002	WO2002083859A2 Surface proteins of streptococcus pyogenes
10/24/2002	WO2002083858A2 Methods to inhibit viral replication
10/24/2002	WO2002083855A2 Novel streptococcus pneumoniae open reading frames encoding polypeptide antigens and uses thereof
10/24/2002	WO2002083841A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
10/24/2002	WO2002083733A2 Polynucleotides and polypeptides of the ifnalpha-6 gene
10/24/2002	WO2002083720A2 Intermediates and enzymes of the non-mevalonate isoprenoid pathway
10/24/2002	WO2002083712A2 Transporters and ion channels
10/24/2002	WO2002083711A2 Molecular mimetics of meningococcal b epitopes which elicit functionally active antibodies
10/24/2002	WO2002083709A2 Kinases and phosphatases
10/24/2002	WO2002083708A2 Selective covalent-binding compounds having therapeutic diagnostic and analytical applications
10/24/2002	WO2002083704A1 Vascular endothelial growth factor 2
10/24/2002	WO2002083692A1 Process for the selective preparation of 3-(z) propenyl-cephem compound
10/24/2002	WO2002083672A1 Antiviral pyrazolopyridine compounds
10/24/2002	WO2002083669A1 Tropane alkaloid multidrug resistance inhibitors from erythroxylum pervillei and use of the same
10/24/2002	WO2002083668A1 Isoxaxole derivatives as inhibitors of src and other protein kinases
10/24/2002	WO2002083667A2 Inhibitors of c-jun n-terminal kinases (jnk) and other protein kinases

1 ... 1250 1251 1252 1253 1254 1255 1256 1257 1258 1259 1260 1261 1262 1263 1264 1265 1266 1267 1268 1269 1270 ... 1798